SAMA ISIN: US80821R1095 Forum: Aktien User: Juk28

Bin hier mit 500 St am Start. Das Thema wird immer mehr Fahrt aufnehmen, gerade im medizinischen Bereich. Und diese Company hat ein super Setup!

Es gibt nun einen Thread um sich über bekannte und neue Merger / IPOs auszutauschen, ähnlich dem Bio oder H2 Sektor. Also wer Lust und Interesse hat mitzumachen ist herzlich willkommen 🤝😉👍 https://www.boersennews.de/community/thema/Acquisition---Merger/46410/

https://www.newcannabisventures.com/

Multi-National Cannabis Operator Clever Leaves Bets on Low-Cost Model and Prepares to Go Public via SPAC September 30, 2020 at 1:30 pm

http://www.globenewswire.com/news-release/2020/09/23/2097973/0/en/Government-of-Colombia-Declares-Clever-Leaves-Colombia-as-Project-of-National-and-Strategic-Interest.html

Government of Colombia Declares Clever Leaves Colombia as ‘Project of National and Strategic Interest’ Priority Status Highlights Government Support; Accelerates Execution of Strategic Projects and Regulatory Processes    September 23, 2020 08:30 ET | Source: Clever Leaves

https://www.streetinsider.com/dr/news.php?id=17320021&gfv=1

Schultze Special Purpose Acquisition Corp. and Clever Leaves to Present at the 9th Annual Gateway Conference on September 9, 2020 September 2, 2020 4:12 PM NEW YORK, NY / ACCESSWIRE / September 2, 2020 / Schultze Special Purpose Acquisition Corp. (NASDAQ:SAMA, SAMAW, and SAMAU) ("SAMA") and Clever Leaves International Inc. ("Clever Leaves" or the "Company") have been invited to present at the 9th Annual Gateway Conference, which is being held virtually on September 9-10, 2020. SAMA and Clever Leaves management are scheduled to present on Wednesday, September �9th at 11:00 a.m. Pacific time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay here.

Portugiesische Produktionsstätte von Clever Leaves erhält Lizenz zum Anbau, Verkauf und Export von medizinischem Cannabis Lizenz markiert den Beginn der europäischen Anbauaktivitäten und etabliert Portugal als europäisches Zentrum für die Produktion von medizinischem Cannabis durch Clever Leaves

https://www.finanznachrichten.de/nachrichten-2020-08/50535866-portugiesische-produktionsstaette-von-clever-leaves-erhaelt-lizenz-zum-anbau-verkauf-und-export-von-medizinischem-cannabis-382.htm

http://www.globenewswire.com/news-release/2020/08/07/2075014/0/en/Schultze-Special-Purpose-Acquisition-Corp-Announces-Filing-of-a-Registration-Statement-on-SEC-Form-S-4-in-Connection-with-its-Proposed-Business-Combination-with-Clever-Leaves-a-Lar.html

RYE BROOK, N.Y., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) announced today that Clever Leaves Holdings Inc. (“Holdco”) filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary proxy statement of SAMA, in connection with its proposed business combination with Clever Leaves International Inc. (“Clever Leaves” or the “Company”) pursuant to which Holdco, a newly formed holding company, will acquire SAMA and Clever Leaves (the “Business Combination”). Holdco is anticipated to become a NASDAQ-listed public company trading under the ticker symbol “CLVR” with an anticipated initial enterprise value of approximately $255 million. Clever Leaves’ executive management team, led by Kyle Detwiler, Chief Executive Officer, and Andrés Fajardo, President, are expected to continue to lead the combined company.

Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) ("SAMA") and Clever Leaves International Inc. ("Clever Leaves" or the "Company") jointly announced today that they have entered into a definitive agreement (the "Business Combination Agreement"), pursuant to which a newly formed holding company, Clever Leaves Holdings Inc., will acquire SAMA and Clever Leaves and is anticipated to become a NASDAQ-listed public company trading under the ticker symbol "CLVR" with an anticipated initial enterprise value of approximately $255 million.

https://finance.yahoo.com/news/schultze-special-purpose-acquisition-corp-120000515.html

Bin mal dabei

Clever Leaves Granted European Union Good Manufacturing Practices (EU GMP) Certification Clever Leaves’ Colombian operation is the first medical cannabis facility to receive EU GMP certification in Latin America